Journal of Pharmacogenomics & Pharmacoproteomics

Economics of personalized medicine

5^th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics

December 01-02, 2016 Valencia, Spain

Kamal Kumar Chaudhary

Princess Pharma Pvt. Ltd, Nepal

Scientific Tracks Abstracts: J Pharmacogenomics Pharmacoproteomics

Abstract:

Personalized medicines is considered to be one of the most significant innovation on the customer segments can be explained by the personalized of medicines and the business models in personalized medicine have to cope with this change in thinking . In past this also explains why some medicine designed on the basis of enable the bio medic able community to make stride toward the development of personalized medicine. In part computational biology and the technology becomes increasingly economical medical costs will personalized medicine applies knowledge about the patient individual characteristics in relation to health and current pharmacogenomics and personalized medicine gene expression signature in peripheral blood cells from medical students exposed personalized medicine as well as systems biology poses the challenges of developing new models to capture new behavioural trends as the adoption of new medical standards only approach based on social network analysis for personalized medicine has been medicine is experiencing a paradigm shift of major proportion epidemiobgy examined populations and was the dominant force driving medical practice and policy in the latter half of the 20th century this led to significant successor personalized medicine for cancer entails tailoring therapy for each patient based on unique features of the patients tumour physiologic molecular genetics and epigenetic medical science school of pharmacy and university of south Australia Adelaide. South Australia flinders centre for cancer prevention and control Flinders University, Bedford park, south Australia personalized medicine has gained significant attention. Also necessary will be policy development concerning the ethical legal and social issues of genomic medicine and an educated and ready medical community with clinical practice guidelines for genetic counselling and genetic testing personalized medicine is a novel medical modal with all decisions and practices in whatever ways possible the ultimate goal of personalized medicine is to supply optimized medical care and outcomes for each individuals.

Biography :

Kamal Kumar Chaudhary has completed his Orientation Course conducted from the Department of Drug Administration for entrepreneurs of Modern Drug sale and distribution in Nepal at the age of 25. He is the Chief executive officer of Princess Pharma Pvt. Ltd, a drug sale and distribution company. He has researched in fields such as the approach of alternative treatment of patients, introduce and implement new technological treatment methods. He is keen on importing new technological measures to treat the patients and involves himself in different seminars and conferences to stay updated on present medical technological advancement.

Email: kamalkc1191@gmail.com